首页 > 最新文献

Journal of the Neurological Sciences最新文献

英文 中文
Importance of focusing on subjective symptoms to maintain quality of life in patients with Parkinson's disease for over 5 years. 关注主观症状对维持帕金森病患者 5 年以上生活质量的重要性。
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-29 DOI: 10.1016/j.jns.2024.123253
Remi Morimoto, Kazuo Kitagawa, Mutsumi Iijima

Parkinson's disease (PD) is a neurodegenerative disorder that causes a variety of motor and non-motor symptoms (NMS), which affect the patient's quality of life (QOL). This study aimed to compare QOL and background in patients with PD based on the disease duration and investigate the factors affecting QOL. Patients with PD were evaluated based on age, sex, disease duration (≤5 years and > 5 years groups), Mini Mental State Examination (MMSE), Japanese version of Montreal Cognitive Assessment (MoCA-J), Levodopa equivalent daily dose (LEDD), Hoehn and Yahr (HY) severity, movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) parts I-IV, and QOL using the Parkinson's disease questionnaire (PDQ-8). Overall, 102 patients with PD (58 males; mean age = 70.0 years; mean disease duration = 7.3 years) were included in this study. QOL was significantly correlated (r > 0.30, p < 0.05) with disease duration and MDS-UPDRS parts I-IV total scores. When the PDQ-8 total score was compared with MDS-UPDRS parts I-IV total scores based on disease duration classification, it was positively correlated with the scores for parts I and II in the >5 years group. Moreover, MDS-UPDRS parts I and II total scores appeared to be the factors most significantly affecting QOL. The factors affecting QOL in patients with PD were subjective NMS and motor symptoms. Since, physician-rated motor symptoms were not associated with QOL in patients with >5 years PD, subjective symptoms should be evaluated and treated to maintain QOL.

帕金森病(Parkinson's disease,PD)是一种神经退行性疾病,会引起各种运动和非运动症状(NMS),影响患者的生活质量(QOL)。本研究旨在根据病程长短比较帕金森病患者的 QOL 和背景,并调查影响 QOL 的因素。研究根据帕金森病患者的年龄、性别、病程(≤5年组和>5年组)、迷你精神状态检查(MMSE)、日语版蒙特利尔认知评估(MoCA-J)、左旋多巴等效日剂量(LEDD)、霍恩和雅尔(HY)严重程度、运动障碍协会发起的统一帕金森病评分量表修订版(MDS-UPDRS)I-IV部分以及使用帕金森病问卷(PDQ-8)进行的QOL进行了评估。本研究共纳入 102 名帕金森病患者(58 名男性;平均年龄 = 70.0 岁;平均病程 = 7.3 年)。患者的 QOL 存在明显相关性(r > 0.30,p 5 年组)。此外,MDS-UPDRS 第一部分和第二部分总分似乎是对 QOL 影响最大的因素。影响帕金森病患者 QOL 的因素是主观 NMS 和运动症状。由于医生评定的运动症状与5年以上帕金森病患者的生活质量无关,因此应评估和治疗主观症状,以维持生活质量。
{"title":"Importance of focusing on subjective symptoms to maintain quality of life in patients with Parkinson's disease for over 5 years.","authors":"Remi Morimoto, Kazuo Kitagawa, Mutsumi Iijima","doi":"10.1016/j.jns.2024.123253","DOIUrl":"https://doi.org/10.1016/j.jns.2024.123253","url":null,"abstract":"<p><p>Parkinson's disease (PD) is a neurodegenerative disorder that causes a variety of motor and non-motor symptoms (NMS), which affect the patient's quality of life (QOL). This study aimed to compare QOL and background in patients with PD based on the disease duration and investigate the factors affecting QOL. Patients with PD were evaluated based on age, sex, disease duration (≤5 years and > 5 years groups), Mini Mental State Examination (MMSE), Japanese version of Montreal Cognitive Assessment (MoCA-J), Levodopa equivalent daily dose (LEDD), Hoehn and Yahr (HY) severity, movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) parts I-IV, and QOL using the Parkinson's disease questionnaire (PDQ-8). Overall, 102 patients with PD (58 males; mean age = 70.0 years; mean disease duration = 7.3 years) were included in this study. QOL was significantly correlated (r > 0.30, p < 0.05) with disease duration and MDS-UPDRS parts I-IV total scores. When the PDQ-8 total score was compared with MDS-UPDRS parts I-IV total scores based on disease duration classification, it was positively correlated with the scores for parts I and II in the >5 years group. Moreover, MDS-UPDRS parts I and II total scores appeared to be the factors most significantly affecting QOL. The factors affecting QOL in patients with PD were subjective NMS and motor symptoms. Since, physician-rated motor symptoms were not associated with QOL in patients with >5 years PD, subjective symptoms should be evaluated and treated to maintain QOL.</p>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to letter from Catamo, Costa, Buque & Nzwalo (2024) titled "Possible role of mycotoxins, malnutrition and MECP2 dysregulation in nodding syndrome" regarding Spencer, Valdes Angues & Palmer's paper titled "Nodding syndrome: A role for environmental biotoxins that dysregulate MECP2 expression?" JNS. 2024;462:123077. Doi: 10.1016/j.jns.2024.123077. 对 Catamo、Costa、Buque 和 Nzwalo (2024) 题为 "霉菌毒素、营养不良和 MECP2 失调在点头综合征中的可能作用 "的信的回复,该信涉及 Spencer、Valdes Angues 和 Palmer 题为 "点头综合征:MECP2 表达失调的环境生物毒素的作用?JNS.2024;462:123077.Doi: 10.1016/j.jns.2024.123077.
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-27 DOI: 10.1016/j.jns.2024.123262
Peter S Spencer, Raquel Valdes Angues, Valerie S Palmer
{"title":"Response to letter from Catamo, Costa, Buque & Nzwalo (2024) titled \"Possible role of mycotoxins, malnutrition and MECP2 dysregulation in nodding syndrome\" regarding Spencer, Valdes Angues & Palmer's paper titled \"Nodding syndrome: A role for environmental biotoxins that dysregulate MECP2 expression?\" JNS. 2024;462:123077. Doi: 10.1016/j.jns.2024.123077.","authors":"Peter S Spencer, Raquel Valdes Angues, Valerie S Palmer","doi":"10.1016/j.jns.2024.123262","DOIUrl":"https://doi.org/10.1016/j.jns.2024.123262","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging transdisciplinary in medical education: A pathway to achieve SDG 3 in Global Health. 医学教育中的跨学科桥梁:在全球健康领域实现可持续发展目标 3 的途径。
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-27 DOI: 10.1016/j.jns.2024.123252
Samudra Mutiara Hasanah, Sri Rahayu, Oktavia Sulistina, Ronal Surya Aditya, Rizky Andana Pohan, Riza Amalia, Adellia Wardatus Sholeha
{"title":"Bridging transdisciplinary in medical education: A pathway to achieve SDG 3 in Global Health.","authors":"Samudra Mutiara Hasanah, Sri Rahayu, Oktavia Sulistina, Ronal Surya Aditya, Rizky Andana Pohan, Riza Amalia, Adellia Wardatus Sholeha","doi":"10.1016/j.jns.2024.123252","DOIUrl":"https://doi.org/10.1016/j.jns.2024.123252","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possible role of mycotoxins, malnutrition and MECP2 dysregulation in nodding syndrome 霉菌毒素、营养不良和 MECP2 失调在结节综合征中可能起的作用
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-26 DOI: 10.1016/j.jns.2024.123261
{"title":"Possible role of mycotoxins, malnutrition and MECP2 dysregulation in nodding syndrome","authors":"","doi":"10.1016/j.jns.2024.123261","DOIUrl":"10.1016/j.jns.2024.123261","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the letter “Acute stroke care inequities: Cross-cultural insights and the need for multi-ethnic research” 对 "急性中风护理不平等:跨文化见解和多种族研究的必要性"。
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-26 DOI: 10.1016/j.jns.2024.123257
{"title":"Response to the letter “Acute stroke care inequities: Cross-cultural insights and the need for multi-ethnic research”","authors":"","doi":"10.1016/j.jns.2024.123257","DOIUrl":"10.1016/j.jns.2024.123257","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142349146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the letter “Racial and Ethnic Disparities in Acute Stroke Treatment Access: Multicultural implications in Universal Healthcare Systems” 对 "急性中风治疗中的种族和民族差异:全民医疗系统中的多元文化影响"。
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-25 DOI: 10.1016/j.jns.2024.123255
{"title":"Response to the letter “Racial and Ethnic Disparities in Acute Stroke Treatment Access: Multicultural implications in Universal Healthcare Systems”","authors":"","doi":"10.1016/j.jns.2024.123255","DOIUrl":"10.1016/j.jns.2024.123255","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142349147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute stroke care inequities: Cross-cultural insights and the need for multi-ethnic research. 急性中风护理的不平等:跨文化见解和多种族研究的必要性。
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-25 DOI: 10.1016/j.jns.2024.123256
Riza Amalia, Ria Angin, Ahmad Razak, Sri Wahyuni Adiningtyas, Rusnila, Ethel Joy V Sebastian, Adellia Wardatus Sholeha
{"title":"Acute stroke care inequities: Cross-cultural insights and the need for multi-ethnic research.","authors":"Riza Amalia, Ria Angin, Ahmad Razak, Sri Wahyuni Adiningtyas, Rusnila, Ethel Joy V Sebastian, Adellia Wardatus Sholeha","doi":"10.1016/j.jns.2024.123256","DOIUrl":"https://doi.org/10.1016/j.jns.2024.123256","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial and ethnic disparities in acute stroke treatment access: Multicultural implications in universal healthcare systems 急性中风治疗中的种族和民族差异:全民医疗系统中的多元文化影响
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-24 DOI: 10.1016/j.jns.2024.123254
{"title":"Racial and ethnic disparities in acute stroke treatment access: Multicultural implications in universal healthcare systems","authors":"","doi":"10.1016/j.jns.2024.123254","DOIUrl":"10.1016/j.jns.2024.123254","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142327150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of quality of care on outcomes in survivors of stroke with aphasia: A linked registry and hospital data observational study 护理质量对中风伴失语症幸存者预后的影响:一项关联登记和医院数据的观察研究
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-21 DOI: 10.1016/j.jns.2024.123251

Background

The impact of hospital care quality on patient outcomes in post-stroke aphasia remains unclear. We investigated the impact of nationally-endorsed acute stroke treatments on outcomes post-stroke, by aphasia status.

Methods

Patient-level data from the Australian Stroke Clinical Registry (2009–2013) linked to national deaths, hospital emergency presentations and admissions data were used. Aphasia was identified for the index stroke event (ICD-10 diagnosis code R47.0). Impact of receiving an optimal stroke care bundle (stroke unit care, antihypertensive medication at discharge and discharge care plan) and an acute ischemic stroke (AIS) care bundle (stroke unit care, intravenous thrombolysis and aspirin within 48 h of admission) on outcomes were analysed using multivariable regression models with propensity score adjustment.

Results

The study included 12,690 patients with a median age of 76, 54 % male, and 26 % with aphasia. Non-receipt of the optimal stroke care bundle was associated with worse survival, compared to optimal care, in people with aphasia (HR: 3.37; 95 % CI 2.10, 5.40; p < 0.05) and without aphasia (HR: 2.10; 95 % CI 1.19, 3.69; p < 0.05). Notably, the dose-response effect on survival was more pronounced in individuals with aphasia. In those who received the AIS care bundle, readmission within 12 months was greater in those without aphasia (vs aphasia, p-value interaction = 0.001), whereas survival was similar (p-value interaction = 0.731).

Conclusions

Survivors of stroke with aphasia who did not receive the optimal stroke care bundle, had worse survival at 12 months post-stroke. Ensuring eligible patients receive the optimal stroke care bundle is crucial for improving their 12-month survival.
背景医院护理质量对卒中后失语症患者预后的影响尚不清楚。我们研究了国家认可的急性卒中治疗方法对卒中后预后的影响(按失语状态分类)。方法:我们使用了澳大利亚卒中临床登记处(2009-2013 年)的患者数据,这些数据与国家死亡、医院急诊和入院数据相关联。失语症是指中风事件(ICD-10 诊断代码 R47.0)。采用多变量回归模型和倾向评分调整分析了接受最佳卒中护理包(卒中单元护理、出院时抗高血压药物和出院护理计划)和急性缺血性卒中(AIS)护理包(卒中单元护理、入院 48 小时内静脉溶栓和阿司匹林)对预后的影响。在有失语症(HR:3.37;95 % CI 2.10,5.40;p <;0.05)和无失语症(HR:2.10;95 % CI 1.19,3.69;p <;0.05)的患者中,与最佳护理相比,未接受最佳卒中护理包的患者生存率更低。值得注意的是,剂量反应对失语症患者生存率的影响更为明显。在接受 AIS 护理综合方案的患者中,无失语症患者在 12 个月内再入院的比例更高(与失语症相比,p 值交互作用 = 0.001),而生存率相似(p 值交互作用 = 0.731)。确保符合条件的患者接受最佳卒中护理包对提高他们的 12 个月生存率至关重要。
{"title":"Impact of quality of care on outcomes in survivors of stroke with aphasia: A linked registry and hospital data observational study","authors":"","doi":"10.1016/j.jns.2024.123251","DOIUrl":"10.1016/j.jns.2024.123251","url":null,"abstract":"<div><h3>Background</h3><div>The impact of hospital care quality on patient outcomes in post-stroke aphasia remains unclear. We investigated the impact of nationally-endorsed acute stroke treatments on outcomes post-stroke, by aphasia status.</div></div><div><h3>Methods</h3><div>Patient-level data from the Australian Stroke Clinical Registry (2009–2013) linked to national deaths, hospital emergency presentations and admissions data were used. Aphasia was identified for the index stroke event (ICD-10 diagnosis code R47.0). Impact of receiving an optimal stroke care bundle (stroke unit care, antihypertensive medication at discharge and discharge care plan) and an acute ischemic stroke (AIS) care bundle (stroke unit care, intravenous thrombolysis and aspirin within 48 h of admission) on outcomes were analysed using multivariable regression models with propensity score adjustment.</div></div><div><h3>Results</h3><div>The study included 12,690 patients with a median age of 76, 54 % male, and 26 % with aphasia. Non-receipt of the optimal stroke care bundle was associated with worse survival, compared to optimal care, in people with aphasia (HR: 3.37; 95 % CI 2.10, 5.40; <em>p</em> &lt; 0.05) and without aphasia (HR: 2.10; 95 % CI 1.19, 3.69; p &lt; 0.05). Notably, the dose-response effect on survival was more pronounced in individuals with aphasia. In those who received the AIS care bundle, readmission within 12 months was greater in those without aphasia (vs aphasia, <em>p</em>-value interaction = 0.001), whereas survival was similar (p-value interaction = 0.731).</div></div><div><h3>Conclusions</h3><div>Survivors of stroke with aphasia who did not receive the optimal stroke care bundle, had worse survival at 12 months post-stroke. Ensuring eligible patients receive the optimal stroke care bundle is crucial for improving their 12-month survival.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142327149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Hemorrhagic shock and encephalopathy syndrome: A call for new clinical criteria for early intervention" [Journal of the Neurological Sciences, 465 (2024) in press (JNS 123207)]. 出血性休克和脑病综合征:呼吁制定早期干预的新临床标准"[《神经科学杂志》,465 (2024) 出版中(JNS 123207)]。
IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-20 DOI: 10.1016/j.jns.2024.123246
Tsuyoshi Aihara, Itaru Hayakawa, Kentaro Ide, Yuichi Abe
{"title":"Corrigendum to \"Hemorrhagic shock and encephalopathy syndrome: A call for new clinical criteria for early intervention\" [Journal of the Neurological Sciences, 465 (2024) in press (JNS 123207)].","authors":"Tsuyoshi Aihara, Itaru Hayakawa, Kentaro Ide, Yuichi Abe","doi":"10.1016/j.jns.2024.123246","DOIUrl":"https://doi.org/10.1016/j.jns.2024.123246","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142290005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Neurological Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1